Dolca Thomas - 04 Jun 2021 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
04 Jun 2021
Net transactions value
$0
Form type
4
Filing time
07 Jun 2021, 21:38:15 UTC
Next filing
31 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Stock Option (Right to Buy) Award $0 +5,948 $0.000000 5,948 04 Jun 2021 Common Stock 5,948 $16.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award will fully vest upon the earlier of 1) the Issuer's next annual stockholder meeting, or 2) June 4, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.